Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail

por Velasquez, Melissa, Flannery, Mara, Badolato, Ryan, Vittitow, Alexandria, McDonald, Ryan D., Tofighi, Babak, Garment, Ann R., Giftos, Jonathan, Lee, Joshua D.
Publicado 2019

Public sector low threshold office-based buprenorphine treatment: outcomes at year 7

por Bhatraju, Elenore Patterson, Grossman, Ellie, Tofighi, Babak, McNeely, Jennifer, DiRocco, Danae, Flannery, Mara, Garment, Ann, Goldfeld, Keith, Gourevitch, Marc N., Lee, Joshua D.
Publicado 2017

Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jai...

por Lee, Joshua D., Malone, Mia, McDonald, Ryan, Cheng, Anna, Vasudevan, Kumar, Tofighi, Babak, Garment, Ann, Porter, Barbara, Goldfeld, Keith S., Matteo, Michael, Mangat, Jasdeep, Katyal, Monica, Giftos, Jonathan, MacDonald, Ross
Publicado 2021